Browsing Tag
Paul Emery
2 posts
AnaptysBio shares soar 37% after rheumatoid arthritis candidate rosnilimab delivers promising Phase 2b trial results
AnaptysBio, Inc. experienced a significant boost in its market performance as shares surged 37% in premarket trading following…
EC approves dosing flexibility for Novartis’s Cosentyx in psoriatic arthritis treatment
The European Commission (EC) has granted Novartis approval for a significant update to the label of its psoriatic…